Abnormal production of the tumor necrosis factor inhibitor etanercept and clinical efficacy of tumor in a patient with PAPA syndrome.

Detalles Bibliográficos
Publicado en:Journal of Pediatrics Vol. 145; no. 6; pp. 851 - 856
Autores principales: Cortis E, De Benedetti F, Insalaco A, Cioschi S, Muratori F, D'Urbano LE, Ugazio AG
Formato: case study research tables/charts Journal Article
Publicado: Elsevier B.V. 2004 Dec
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106508822&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106508822
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00223476
        04M
      jtl: Journal of Pediatrics
      issn: 00223476
      maglogo: N
    pubinfo:
      dt: 2004 Dec
      vid: 145
      iid: 6
      pid: 467
      pub: Elsevier B.V.
      place: New York, New York
    artinfo:
      ui:
        106508822
        106508822
        2009012254
        10.1016/j.jpeds.2004.08.001
        NLM15580218
        106508822
      ppf: 851
      ppct: 5
      formats:
      tig:
        atl: Abnormal production of the tumor necrosis factor inhibitor etanercept and clinical efficacy of tumor in a patient with PAPA syndrome.
      aug:
        au:
          Cortis E
          De Benedetti F
          Insalaco A
          Cioschi S
          Muratori F
          D'Urbano LE
          Ugazio AG
        affil: Department of Medicine, Division of Rheumathology and Laboratory of Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy; cortis@opbg.net
      sug:
        subj:
          Acne Vulgaris Complications
          Arthritis Complications
          Etanercept Therapeutic Use
          Immunoglobulins Therapeutic Use
          Pyoderma Complications
          Acne Vulgaris Drug Therapy
          Acne Vulgaris Familial and Genetic
          Adolescence
          Adult
          Arthritis Drug Therapy
          Arthritis Familial and Genetic
          Child
          Child, Preschool
          Cytoskeletal Proteins
          Etanercept Administration and Dosage
          Female
          Male
          Mutation
          Pedigree
          Pyoderma Drug Therapy
          Pyoderma Familial and Genetic
          Syndrome
          Human
          Adolescent: 13-18 years
          Adult: 19-44 years
          Child: 6-12 years
          Child, Preschool: 2-5 years
          Female
          Male
      pubtype: Academic Journal
      doctype:
        case study
        research
        tables/charts
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N